Teva Pharmaceutical Industries Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TEVJF research report →
Companywww.tevapharm.com
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients.
- CEO
- Richard D. Francis
- IPO
- 2010
- Employees
- 37,000
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $35.15B
- P/E
- 25.38
- P/S
- 2.31
- P/B
- 4.81
- EV/EBITDA
- 16.13
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 51.98%
- Op Margin
- 19.38%
- Net Margin
- 9.03%
- ROE
- 20.79%
- ROIC
- 11.49%
Growth & Income
- Revenue
- $18.68B · 12.92%
- Net Income
- $1.53B · 193.19%
- EPS
- $1.33 · 191.72%
- Op Income
- $2.16B
- FCF YoY
- 241.36%
Performance & Tape
- 52W High
- $37.00
- 52W Low
- $13.73
- 50D MA
- $28.68
- 200D MA
- $20.12
- Beta
- 0.86
- Avg Volume
- 10
Get TickerSpark's AI analysis on TEVJF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 20, 23 | Fox Christine | other | 253,968 |
| Nov 20, 23 | Fox Christine | other | 0 |
| Nov 15, 23 | Conway Vikki L | other | 33,482 |
| Nov 15, 23 | Bergwerk Dov | other | 33,482 |
| Oct 13, 23 | Bergwerk Dov | other | 0 |
| Oct 13, 23 | Bergwerk Dov | other | 17,505 |
| Oct 13, 23 | Bergwerk Dov | other | 7,010 |
| Oct 13, 23 | Bergwerk Dov | other | 31,075 |
| Oct 13, 23 | Bergwerk Dov | other | 27,501 |
| Oct 13, 23 | Bergwerk Dov | other | 12,754 |
Our TEVJF Coverage
We haven't published any research on TEVJF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TEVJF Report →